The side effects of cholesterol-lowering drugs (incl. increasing the risk of diabetes in some people) is dwarfed by the benefits of the statins (incl. preventing cardiovascular deaths)

Using a sample of 17,603 men and women, a team of researchers led by Prof. Paul Ridker of Brigham and Women's Hospital in Boston, found there are more benefits of taking cholesterol-lowering medications than risks.  In recent years health experts have identified their concerns regarding the side effects of statins (such as Lipitor, Crestor, and others), including increasing the risk of diabetes in some people.

Prof. Ridker and colleagues believe that patients who are taking statins experienced significant reductions in their chance of getting cardiovascular diseases, including heart attack and stroke.  The study was funded by AstraZeneca (the drug maker of Crestor) and is being published in The Lancet.

Researchers found that some people could increase their risk of diabetes while taking statins.  The study found people with higher chances to carry positive diabetes risk factors are people who are obesity and have high blood sugar levels.

(Image: Crestor)

Comments

[Blog GildedDiva]

Hey there ! What a lovely looking personal site you have! Did you apply all the settings to your domain by yourself?

[replica rolex watches]

Researchers found that some people could increase their risk of diabetes while taking statins. The study found people with higher chances to carry positive diabetes risk factors are people who are obesity and have high blood sugar levels.

[replica handbags]

Sometimes when tornadoes hit lives metaphorically, it would be nice to be able to restrict them to a penned in area! Very interesting drawing of a volatile force. Something powerful and yet peaceful about it!

[gucci handbags outlet]

Ridker and colleagues believe that patients who are taking statins experienced significant reductions in their chance of getting cardiovascular diseases, including heart attack and stroke. The study was funded by AstraZeneca (the drug maker of Crestor) and is being published in The Lancet.